eNewsroom for: Rosa and Co.

Rosa helps clients with their critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of R&D related challenges, Rosa offers customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these capabilities, Rosa’s clients participate in customized model creation, testing, and research simulations, retain the models, and acquire the ability to perform model research to inform decisions and better understand implications for their drug development programs. Rosa’s staff has unparalleled professional experience in applying modeling and simulation to accelerate drug development and have completed hundreds of engagements with clients in virtually all therapeutic areas, including metabolic diseases, oncology, inflammation, immune dysfunction, CNS, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.

News from Rosa and Co.:

Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting

SAN CARLOS, Calif., March 3, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation research, today announced it has two posters scheduled to be presented during the 2015 American Society for Clinical Pharmacology and…

The KressWorks Foundation and Rosa Complete Phase 1 of Ewing's Sarcoma PhysioPD™ Research Platform

SAN CARLOS, Calif., March 28, 2014 /PRNewswire/ — Rosa & Co. LLC and the KressWorks Foundation are pleased to announce the completion of the Ewing's sarcoma PhysioMap®. Completion of the PhysioMap is the first milestone in the development of the Ewing's sarcoma PhysioPD Plat…